Workflow
RYC(003010)
icon
Search documents
若羽臣:2023年度财务决算报告
2024-04-28 07:47
广州若羽臣科技股份有限公司 2023 年度财务决算报告 广州若羽臣科技股份有限公司(以下简称"公司")2023 年度财务会计报表按照国务院颁 布的《企业会计准则》以及财政部印发的关于会计报表的有关规定编制完成,在所有重大方面 公允的反映了公司 2023 年 12 月 31 日的合并财务状况以及 2023 年度的合并经营成果和现金流 量。天健会计师事务所(特殊普通合伙)对公司 2023 年度财务报表进行了审计验证并对此出 具了标准无保留意见的审计报告。 二、财务状况、经营成果和现金流量分析 (一)资产、负债和净资产情况 1、资产构成及变动情况 2023 年 2022 年 本年比上年 增减 2021 年 调整前 调整后 调整后 调整前 调整后 营业收入(元) 1,366,090,534.21 1,216,981,835 .30 1,216,981,835 .30 12.25% 1,288,453,356 .23 1,288,453,35 6.23 归属于上市公司股东的 净利润(元) 54,290,476.45 33,756,029.72 33,736,009.23 60.93% 29,195,137.60 29, ...
若羽臣:内部控制自我评价报告
2024-04-28 07:47
广州若羽臣科技股份有限公司全体股东: 广州若羽臣科技股份有限公司 2023 年度内部控制评价报告 根据《企业内部控制基本规范》及其配套指引的规定和其他内部控制监管要 求(以下简称企业内部控制规范体系),结合广州若羽臣科技股份有限公司(以 下简称"公司")内部控制制度和评价办法,在内部控制日常监督和专项监督的 基础上,我们对公司截至 2023 年 12 月 31 日(内部控制评价报告基准日)的内 部控制有效性进行了评价。 一、重要声明 按照企业内部控制规范体系的规定,建立健全和有效实施内部控制,评价其 有效性,并如实披露内部控制评价报告是公司董事会的责任。监事会对董事会建 立和实施内部控制进行监督。经理层负责组织领导企业内部控制的日常运行。公 司董事会、监事会及董事、监事、高级管理人员保证本报告内容不存在任何虚假 记载、误导性陈述或重大遗漏,并对报告内容的真实性、准确性和完整性承担个 别及连带法律责任。 公司内部控制的目标是合理保证经营管理合法合规、资产安全、财务报告及 相关信息真实完整,提高经营效率和效果,促进实现发展战略。由于内部控制存 在的固有局限性,故仅能为实现上述目标提供合理保证。此外,由于情况的变化 ...
若羽臣(003010) - 2024 Q1 - 季度财报
2024-04-28 07:47
Financial Performance - The company's revenue for Q1 2024 reached ¥372,228,772.95, representing a 31.68% increase compared to ¥282,670,941.40 in the same period last year[5] - Net profit attributable to shareholders was ¥12,821,237.60, an increase of 86.40% from ¥6,878,378.02 year-on-year[5] - The basic earnings per share rose to ¥0.1051, reflecting an 86.02% increase compared to ¥0.0565 in the same period last year[5] - Operating profit for the quarter was CNY 12,844,638.82, up 89.5% from CNY 6,774,581.79 in Q1 2023[24] - Total comprehensive income attributable to the parent company reached CNY 13,039,623.35, a significant increase from CNY 6,890,586.74 in the previous period, representing an increase of approximately 89.5%[25] Cash Flow and Assets - The net cash flow from operating activities surged by 177.96% to ¥121,475,841.73, up from ¥43,702,478.32 in the previous year[5] - Cash received from the sale of goods and services amounted to CNY 457,359,013.66, up from CNY 307,202,992.85, indicating a growth of 48.9%[26] - Cash and cash equivalents increased to RMB 402,308,689.92 from RMB 345,454,763.98, representing a growth of about 16.4%[19] - The net increase in cash and cash equivalents for the period was CNY 59,603,559.50, compared to CNY 26,621,713.07 in the previous period, reflecting an increase of 123.8%[26] - Cash and cash equivalents at the end of the period totaled CNY 395,929,360.45, slightly up from CNY 395,196,574.79 in the previous period[26] Liabilities and Equity - Total liabilities increased to CNY 249,295,646.01 from CNY 248,603,008.85, indicating a marginal rise in financial obligations[21] - The total equity attributable to shareholders decreased to CNY 1,050,144,897.19 from CNY 1,097,095,387.79, indicating a reduction in shareholder value[21] Inventory and Operating Costs - The company experienced a 51.96% increase in operating costs, amounting to ¥280,485,010.37, due to the corresponding increase in revenue[8] - The company's inventory stock increased by 211.24% to ¥88,388,744.57, primarily due to the execution of a share buyback[8] - Inventory decreased significantly from RMB 318,580,274.72 to RMB 241,454,933.74, a decline of around 24.2%[19] Share Repurchase - The company repurchased a total of 2,151,900 shares, accounting for 1.76% of the total share capital, with a total transaction amount of RMB 29,994,796.00[13] - The total amount allocated for share repurchase is between RMB 15 million and RMB 30 million, with a maximum repurchase price set at RMB 30.20 per share[12] - The company plans to continue its share repurchase program for an additional 12 months following the board's approval[14] Government Subsidies and Other Income - The company reported a significant increase in government subsidies, totaling ¥803,073.00, which is an increase of 877.47% compared to ¥82,158.67 in the previous year[8] - The company reported a significant increase in other receivables, rising from RMB 47,600,376.17 to RMB 64,376,811.61, an increase of approximately 35.2%[19] Financial Adjustments and Future Plans - The company has appointed a new quality control reviewer for its accounting firm due to internal adjustments, ensuring continuity in the audit process[17] - The company plans to continue focusing on market expansion and new product development to drive future growth[22] - The report indicates the implementation of new accounting standards starting in 2024, which may affect future financial reporting[27] - The company has not undergone an audit for the first quarter report[27]
若羽臣:年度募集资金使用鉴证报告
2024-04-28 07:44
目 录 一、募集资金年度存放与使用情况鉴证报告………………………第 1—2 页 二、关于募集资金年度存放与使用情况的专项报告………………第 3—9 页 三、资质证书复印件………………………………………………第 10—13 页 募集资金年度存放与使用情况鉴证报告 天健审〔2024〕7-654 号 广州若羽臣科技股份有限公司全体股东: 我们鉴证了后附的广州若羽臣科技股份有限公司(以下简称若羽臣)管理层 编制的 2023 年度《关于募集资金年度存放与使用情况的专项报告》。 一、对报告使用者和使用目的的限定 本鉴证报告仅供若羽臣年度报告披露时使用,不得用作任何其他目的。我们 同意将本鉴证报告作为若羽臣年度报告的必备文件,随同其他文件一起报送并对 外披露。 第1页 共13页 四、工作概述 我们按照中国注册会计师执业准则的规定执行了鉴证业务。中国注册会计师 执业准则要求我们计划和实施鉴证工作,以对鉴证对象信息是否不存在重大错报 获取合理保证。在鉴证过程中,我们实施了包括核查会计记录等我们认为必要的 程序。我们相信,我们的鉴证工作为发表意见提供了合理的基础。 五、鉴证结论 我们认为,若羽臣管理层编制的 2023 年度《关于 ...
若羽臣:内部控制审计报告
2024-04-28 07:44
目 录 内部控制审计报告 天健审〔2024〕7-653 号 广州若羽臣科技股份有限公司全体股东: 按照《企业内部控制审计指引》及中国注册会计师执业准则的相关要求,我 们审计了广州若羽臣科技股份有限公司(以下简称若羽臣)2023 年 12 月 31 日 的财务报告内部控制的有效性。 一、企业对内部控制的责任 按照《企业内部控制基本规范》《企业内部控制应用指引》以及《企业内部 控制评价指引》的规定,建立健全和有效实施内部控制,并评价其有效性是若羽 臣董事会的责任。 二、注册会计师的责任 我们的责任是在实施审计工作的基础上,对财务报告内部控制的有效性发表 审计意见,并对注意到的非财务报告内部控制的重大缺陷进行披露。 三、内部控制的固有局限性 | | | 内部控制具有固有局限性,存在不能防止和发现错报的可能性。此外,由于 情况的变化可能导致内部控制变得不恰当,或对控制政策和程序遵循的程度降低, 根据内部控制审计结果推测未来内部控制的有效性具有一定风险。 四、财务报告内部控制审计意见 我们认为,若羽臣于 2023 年 12 月 31 日按照《企业内部控制基本规范》和 天健会计师事务所(特殊普通合伙) 中国注册会计师: ...
若羽臣:监事会决议公告
2024-04-28 07:44
一、监事会会议召开情况 广州若羽臣科技股份有限公司(以下简称"公司")第三届监事会第二十一次 会议于 2024 年 4 月 15 日以电子邮件形式发出会议通知,于 2024 年 4 月 25 日下 午 16:00 在广州市天河区高德置地冬广场 G 座 32 楼会议室以现场表决的方式召 开,由监事会主席庞小龙先生召集并主持,本次会议应出席监事 3 名,实际出席 监事 3 名,董事会秘书列席会议。会议召开符合法律法规、《公司法》及《公司章 程》的规定。 二、监事会会议审议情况 证券代码:003010 证券简称:若羽臣 公告编号:2024-030 广州若羽臣科技股份有限公司 第三届监事会第二十一次会议决议公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整,没有 虚假记载、误导性陈述或重大遗漏。 与会监事对本次会议需审议的议案进行了充分讨论,审议通过了以下议案: 1、审议通过《公司 2023 年监事会工作报告》; 2023 年度,公司监事会按照《公司法》等相关法律、法规及《公司章程》的 有关规定认真履行职责。结合 2023 年度的主要工作情况,公司监事会制定了 《2023 年监事会工作报告》。 具体内容详 ...
若羽臣:关于会计师事务所2023年度履职情况评估及审计委员会履行监督职责情况报告
2024-04-28 07:44
广州若羽臣科技股份有限公司 关于会计师事务所 2023 年度履职情况评估报告 及审计委员会履行监督职责情况报告 根据《中华人民共和国公司法》《中华人民共和国证券法》《上市公司治理 准则》《国有企业、上市公司选聘会计师事务所管理办法》《深圳证券交易所上 市公司自律监管指引第 1 号——主板上市公司规范运作》和《公司章程》等规定 和要求,广州若羽臣科技股份有限公司(以下简称"公司")董事会审计委员会 本着勤勉尽责的原则,恪尽职守,认真履职。现将审计委员会对会计师事务所 2023 年度履职评估及履行监督职责的情况汇报如下: 一、2023 年年审会计师事务所基本情况 名称:天健会计师事务所(特殊普通合伙) 成立日期:2011 年 7 月 18 日 组织形式:特殊普通合伙 注册地址:浙江省杭州市西湖区灵隐街道西溪路 128 号 首席合伙人:王国海 天健会计师事务所(特殊普通合伙)(以下简称"天健会计师事务所")2023 年度业务收入总额为 34.83 亿元,其中,审计业务收入为 30.99 亿元,证券业务 收入为 18.40 亿元。2023 年度,上市公司审计客户家数 675 家,审计收费总额 6.63 亿元,涉及的主 ...
若羽臣:2023年度监事会工作报告
2024-04-28 07:44
广州若羽臣科技股份有限公司 2023 年度监事会工作报告 2023 年度,在广州若羽臣科技股份有限公司(以下简称"公司")董事会和管 理层的支持和配合下,公司监事会全体成员严格遵守《公司法》《证券法》《深 圳证券交易所股票上市规则》等法律、法规、规范性文件及《公司章程》相关规 定,本着对股东和公司负责的态度,积极有效地开展工作,勤勉、诚实地履行职 能,对公司经营决策程序、依法运作情况、财务状况以及内部管理等方面进行了 核查,并对公司董事和高级管理人员的日常履职情况进行了有效监督,较好地保 障了股东权益、公司利益和员工的合法权益不受侵犯。现将 2023 年度监事会工 作报告汇报如下: 一、监事会会议召开情况 2023 年,公司共召开了 6 次监事会。公司监事会严格遵守《公司法》《公司 章程》《监事会议事规则》中的有关规定,对公司的相关事项做出了决策,会议 的召开程序规范,具体情况如下: | 序号 | 会议召开 日期 | 会议名称 | 审议事项 年监事会工作报告》; 1.《公司 2022 | | --- | --- | --- | --- | | | | | 2.《公司 2022 年度财务决算报告》; 3.《公司 ...
若羽臣(003010) - 2023 Q4 - 年度财报
2024-04-28 07:44
Financial Performance - The company reported a total revenue of RMB 1.2 billion for the year 2023, representing a year-over-year increase of 15% compared to 2022[19]. - The net profit for 2023 was RMB 150 million, which is a 10% increase from the previous year[19]. - The company's operating revenue for 2023 was ¥1,366,090,534, representing a 12.25% increase compared to ¥1,216,981,835 in 2022[26]. - Net profit attributable to shareholders for 2023 was ¥54,290,476.45, a significant increase of 60.93% from ¥33,756,029.72 in 2022[26]. - The net profit after deducting non-recurring gains and losses was ¥53,724,429.13, up 69.15% from ¥31,781,021.39 in the previous year[26]. - The company aims to achieve a revenue target of RMB 1.5 billion for 2024, reflecting a growth rate of 25%[19]. - In 2023, the company achieved operating revenue of 1.366 billion CNY, a year-on-year increase of 12.25%[71]. - The net profit attributable to shareholders reached 54.29 million CNY, up 60.93% compared to the previous year[71]. - The self-owned brand business generated revenue of 263.28 million CNY, a significant increase of 63.63%, accounting for 19.27% of total revenue[71]. User Growth and Market Expansion - User data showed an increase in active users by 20%, reaching a total of 5 million active users by the end of 2023[19]. - The company plans to expand its market presence in Southeast Asia, targeting a 25% growth in that region by 2025[19]. - The company is exploring potential mergers and acquisitions to enhance its product offerings and market share[19]. - The company is focusing on expanding its market presence and developing new products and technologies to drive future growth[177]. Product Development and Innovation - A new product line is set to launch in Q3 2024, expected to contribute an additional RMB 300 million in revenue[19]. - The company has allocated RMB 50 million for research and development in new technologies for 2024[19]. - The company emphasizes a full-chain digital capability to empower brand growth throughout their lifecycle, covering aspects from product design to marketing strategies[40]. - The company is committed to enhancing its digital capabilities to support efficient business operations and reduce costs[147]. - The company has launched multiple successful products, including a series of high-quality items under its own brand, enhancing market presence[66]. Financial Management and Investments - The company reported a significant investment of CNY 21,738,095.68 during the reporting period, a decrease of 80.29% compared to the previous year[116]. - The company has established a special account for the raised funds, ensuring all unused funds are stored according to regulations[135]. - The company has committed to timely information disclosure in accordance with the regulations of the Shenzhen Stock Exchange[123]. - The company has established a comprehensive risk management strategy for its financial derivatives business, focusing on hedging to avoid speculative trading[123]. Governance and Compliance - The governance structure includes a board of 7 members, with 3 independent directors, ensuring compliance with legal requirements[157]. - The company has not engaged in any illegal or non-compliant activities during the reporting period, ensuring good governance practices[156]. - The company has a robust information disclosure system, ensuring transparency and compliance with regulatory requirements[160]. - The company has established an independent financial accounting system and management structure, ensuring no interference from controlling shareholders in financial operations[169]. Operational Efficiency and Cost Management - The company's gross profit margin improved by 6.63 percentage points due to enhanced supply chain management and cost control measures[82]. - The company has a systematic approach to inventory management, including safety stock and economic order quantity assessments[50]. - The company has implemented a browser plugin for automated web content collection, significantly increasing data collection efficiency and reducing operational costs[100]. - The logistics billing automation system was developed to manage and control logistics costs effectively[100]. Talent Development and Human Resources - The company has a strong talent pool with over 300 professionals in the health sector since entering the market in 2016[63]. - The company has established a talent development program called "Sirius Plan" to cultivate young high-potential employees[149]. - The age structure of R&D personnel saw a notable change, with those aged 30-40 increasing by 48.15%, indicating a shift towards more experienced staff[101]. Strategic Partnerships and Collaborations - The company has established strategic partnerships with several international brands, enhancing its brand management capabilities and market presence[73]. - The company is pursuing a dual-line strategy to develop its own brand while also integrating global health resources through investments and acquisitions[146]. Shareholder Engagement and Communication - The company actively manages investor relations, enhancing communication through regular performance briefings and investor visits[161]. - The company held a half-year performance briefing on September 7, 2023, addressing operational conditions and future development plans[150]. - All board members attended the shareholder meetings, ensuring active engagement with stakeholders[196].
若羽臣:年度股东大会通知
2024-04-28 07:44
广州若羽臣科技股份有限公司 关于召开公司 2023 年年度股东大会的通知 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假 记载、误导性陈述或重大遗漏。 广州若羽臣科技股份有限公司(以下简称"公司")于2024年4月25日召开第 三届董事会第二十三次会议,审议通过了《关于召开公司2023年年度股东大会的议 案》。现将本次会议有关事项通知如下: 一、召开会议的基本情况 证券代码:003010 证券简称:若羽臣 公告编号:2024-040 1.股东大会届次:2023年年度股东大会。 2.股东大会的召集人:公司董事会。 3.会议召开的合法、合规性:经公司第三届董事会第二十三次会议审议通过, 决定召开本次股东大会,符合有关法律、行政法规、部门规章、规范性文件和公司 章程等的规定。 4.会议召开的日期、时间: (1)现场会议召开时间:2024年5月28日(周二)15:00。 (2)网络投票时间:2024年5月28日。其中: A、通过深圳证券交易所交易系统投票的时间为:2024年5月28日9:15-9:25, 9:30-11:30和13:00-15:00; B、通过深圳证券交易所互联网投票系统投票的时间 ...